Carrie K. Jones
Vanderbilt University
H-index: 53
North America-United States
Top articles of Carrie K. Jones
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Evaluation of the Indazole Analogs of 5-MeO-DMT and Related Tryptamines as Serotonin Receptor 2 Agonists | ACS Medicinal Chemistry Letters | Navoda Jayakodiarachchi Mallory A Maurer Daniel C Schultz Cayden J Dodd Analisa Thompson Gray | 2024/1/19 |
Competitive and noncompetitive inhibitors of the muscarinic acetylcholine receptor m5 | 2023/6/15 | ||
M1/M4-Preferring Muscarinic Cholinergic Receptor Agonist Xanomeline Reverses Wake and Arousal Deficits in Nonpathologically Aged Mice | ACS Chemical Neuroscience | Jason K Russell Shalonda M Ingram Laura B Teal Craig W Lindsley Carrie K Jones | 2023/1/19 |
M₁-selective muscarinic allosteric modulation enhances cognitive flexibility and effective salience in nonhuman primates. | PNAS Proceedings of the National Academy of Sciences of the United States of America | Seyed A Hassani Adam Neumann Jason Russell Carrie K Jones Thilo Womelsdorf | 2023/5/2 |
Organisation of UK hospitals and anaesthetic departments in the treatment of peri‐operative cardiac arrest: an analysis from the 7th National Audit Project (NAP7) local co … | Anaesthesia | E Kursumovic J Soar JP Nolan F Plaat AD Kane | 2023/12 |
Cholinergic neurotransmission | Brett A English Carrie K Jones | 2023/1/1 | |
M1-selective muscarinic allosteric modulation enhances cognitive flexibility and effective salience in nonhuman primates | Proceedings of the National Academy of Sciences | Seyed A Hassani Adam Neumann Jason Russell Carrie K Jones Thilo Womelsdorf | 2023/5/2 |
The 7th National Audit Project (NAP7) baseline survey of individual anaesthetists: preparedness for and experiences of peri‐operative cardiac arrest | Anaesthesia | E Kursumovic TM Cook DN Lucas MT Davies S Martin | 2023/12 |
Decreased expression of ribosomal protein Rpl3 contributes to behavioral deficits caused by Shank3 deficiency | Chiara Verpelli Federica Giona Stefania Beretta Antonio Zippo Cinzia Vicidomini | 2023/4/25 | |
Development of Potent and Selective Negative Allosteric Modulators of the Metabotropic Glutamate Receptor 2 for the Potential Treatment of Alzheimer’s Disease | Alzheimer's & Dementia | Jeremy S Coleman Rory A Capstick Upendra A Rathnayake Lauren Parr Sichen Chang | 2023/12 |
Selective M5 muscarinic acetylcholine receptor negative allosteric modulator VU6008667 blocks acquisition of opioid self-administration | Neuropharmacology | Laura B Teal Michael Bubser Edith Duncan Robert W Gould Craig W Lindsley | 2023/4/1 |
The M4 muscarinic acetylcholine receptor positive allosteric modulator VU0467154 normalizes non‐rapid eye movement sleep deficits in non‐pathologically aged … | Alzheimer's & Dementia | Jason K Russell Laura Wan Shalonda Ingram Michael Bubser Craig W Lindsley | 2023/12 |
The Evolving Role of Animal Models in the Discovery and Development of Novel Treatments for Psychiatric Disorders | Laura B Teal Shalonda M Ingram Michael Bubser Elliott McClure Carrie K Jones | 2023/3/17 | |
The M1 Muscarinic Acetylcholine Receptor Positive Allosteric Modulator (PAM) VU0453595 and M4 PAM VU0467154 Normalize Sleep‐Wake Architecture Deficits in Aged Mice | Alzheimer's & Dementia | Jason K Russell Michael Bubser Shalonda Ingram Paul A Newhouse Craig W Lindsley | 2022/12 |
Preclinical target validation for non-addictive therapeutics development for pain | Richard Hargreaves Karen Akinsanya Seena K Ajit Neel T Dhruv Jamie Driscoll | 2022/9/2 | |
The astropy project: sustaining and growing a community-oriented open-source project and the latest major release (v5. 0) of the core package | The Astrophysical Journal | Adrian M Price-Whelan Pey Lian Lim Nicholas Earl Nathaniel Starkman Larry Bradley | 2022/8/24 |
Discovery of a potent M5 antagonist with improved clearance profile. Part 2: Pyrrolidine amide-based antagonists | Bioorganic & Medicinal Chemistry Letters | Rory A Capstick David Whomble Douglas L Orsi Andrew S Felts Alice L Rodriguez | 2022/11/15 |
Development of VU6019650: A Potent, Highly Selective, and Systemically Active Orthosteric Antagonist of the M5 Muscarinic Acetylcholine Receptor for the … | Journal of Medicinal Chemistry | Aaron T Garrison Douglas L Orsi Rory A Capstick David Whomble Jinming Li | 2022/4/13 |
Dissociating the pro‐cognitive effects of donepezil and an M1 PAM | Alzheimer's & Dementia | Seyed‐Alireza Hassani Adam Neumann Jason K Russell Carrie K Jones Thilo Womelsdorf | 2022/12 |
M1 muscarinic acetylcholine receptor positive allosteric modulators do not disrupt sleep in aged cynomolgus macaques | Alzheimer's & Dementia | Robert W Gould Alex D Lekander C Ryan Curry Nina Lavalley Jason K Russell | 2022/12 |
